| pubmed-article:3593899 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3593899 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:3593899 | lifeskim:mentions | umls-concept:C0011777 | lld:lifeskim |
| pubmed-article:3593899 | lifeskim:mentions | umls-concept:C0599126 | lld:lifeskim |
| pubmed-article:3593899 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:3593899 | pubmed:dateCreated | 1987-8-17 | lld:pubmed |
| pubmed-article:3593899 | pubmed:abstractText | Dexamethasone in form of its phosphate was given intravenously in two different doses (1.5 mg kg-1 and 15 mg). Plasma levels of the ester and dexamethasone were measured and pharmacokinetic parameters were calculated. The results indicate no dose-dependency of the pharmacokinetic parameters in the investigated range for dexamethasone. Conversion from the prodrug to the active form was rapid; maximum dexamethasone plasma concentrations were reached after 10 min. The results were verified by dexamethasone level monitoring in patients after chronic dosing. Predicted and achieved steady state levels agreed well. | lld:pubmed |
| pubmed-article:3593899 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3593899 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3593899 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3593899 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3593899 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3593899 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3593899 | pubmed:issn | 0142-2782 | lld:pubmed |
| pubmed-article:3593899 | pubmed:author | pubmed-author:MöllmannHH | lld:pubmed |
| pubmed-article:3593899 | pubmed:author | pubmed-author:RohdewaldPP | lld:pubmed |
| pubmed-article:3593899 | pubmed:author | pubmed-author:BartlFF | lld:pubmed |
| pubmed-article:3593899 | pubmed:author | pubmed-author:DerendorfHH | lld:pubmed |
| pubmed-article:3593899 | pubmed:author | pubmed-author:RehderJJ | lld:pubmed |
| pubmed-article:3593899 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3593899 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:3593899 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3593899 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3593899 | pubmed:pagination | 205-12 | lld:pubmed |
| pubmed-article:3593899 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:3593899 | pubmed:meshHeading | pubmed-meshheading:3593899-... | lld:pubmed |
| pubmed-article:3593899 | pubmed:meshHeading | pubmed-meshheading:3593899-... | lld:pubmed |
| pubmed-article:3593899 | pubmed:meshHeading | pubmed-meshheading:3593899-... | lld:pubmed |
| pubmed-article:3593899 | pubmed:meshHeading | pubmed-meshheading:3593899-... | lld:pubmed |
| pubmed-article:3593899 | pubmed:meshHeading | pubmed-meshheading:3593899-... | lld:pubmed |
| pubmed-article:3593899 | pubmed:meshHeading | pubmed-meshheading:3593899-... | lld:pubmed |
| pubmed-article:3593899 | pubmed:meshHeading | pubmed-meshheading:3593899-... | lld:pubmed |
| pubmed-article:3593899 | pubmed:articleTitle | Pharmacokinetics of dexamethasone and its phosphate ester. | lld:pubmed |
| pubmed-article:3593899 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3593899 | lld:pubmed |
